Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 61

1.

MYC Modulation around the CDK2/p27/SKP2 Axis.

Hydbring P, Castell A, Larsson LG.

Genes (Basel). 2017 Jun 30;8(7). pii: E174. doi: 10.3390/genes8070174. Review.

2.

Progesterone receptor blockade in human breast cancer cells decreases cell cycle progression through G2/M by repressing G2/M genes.

Clare SE, Gupta A, Choi M, Ranjan M, Lee O, Wang J, Ivancic DZ, Kim JJ, Khan SA.

BMC Cancer. 2016 May 23;16:326. doi: 10.1186/s12885-016-2355-5.

3.

Survive or die? c-MYC has the last word.

Wu S, Yin X, Liu X, Chu L.

Cell Death Dis. 2015 Dec 17;6:e2017. doi: 10.1038/cddis.2015.366. No abstract available.

4.

Lipin1 Regulates Skeletal Muscle Differentiation through Extracellular Signal-regulated Kinase (ERK) Activation and Cyclin D Complex-regulated Cell Cycle Withdrawal.

Jiang W, Zhu J, Zhuang X, Zhang X, Luo T, Esser KA, Ren H.

J Biol Chem. 2015 Sep 25;290(39):23646-55. doi: 10.1074/jbc.M115.686519. Epub 2015 Aug 20.

5.

ERK as a model for systems biology of enzyme kinetics in cells.

Futran AS, Link AJ, Seger R, Shvartsman SY.

Curr Biol. 2013 Nov 4;23(21):R972-9. doi: 10.1016/j.cub.2013.09.033. Review.

6.

Neuroblastoma and MYCN.

Huang M, Weiss WA.

Cold Spring Harb Perspect Med. 2013 Oct 1;3(10):a014415. doi: 10.1101/cshperspect.a014415. Review.

7.

Transcriptional regulation of flotillins by the extracellularly regulated kinases and retinoid X receptor complexes.

Banning A, Ockenga W, Finger F, Siebrasse P, Tikkanen R.

PLoS One. 2012;7(9):e45514. doi: 10.1371/journal.pone.0045514. Epub 2012 Sep 18.

8.

Systems-pharmacology dissection of a drug synergy in imatinib-resistant CML.

Winter GE, Rix U, Carlson SM, Gleixner KV, Grebien F, Gridling M, Müller AC, Breitwieser FP, Bilban M, Colinge J, Valent P, Bennett KL, White FM, Superti-Furga G.

Nat Chem Biol. 2012 Nov;8(11):905-912. doi: 10.1038/nchembio.1085. Epub 2012 Sep 30.

9.

Polycomb repressive complex 2 is necessary for the normal site-specific O-GlcNAc distribution in mouse embryonic stem cells.

Myers SA, Panning B, Burlingame AL.

Proc Natl Acad Sci U S A. 2011 Jun 7;108(23):9490-5. doi: 10.1073/pnas.1019289108. Epub 2011 May 23.

10.

ERK1/2 MAP kinases promote cell cycle entry by rapid, kinase-independent disruption of retinoblastoma-lamin A complexes.

Rodríguez J, Calvo F, González JM, Casar B, Andrés V, Crespo P.

J Cell Biol. 2010 Nov 29;191(5):967-79. doi: 10.1083/jcb.201004067. Erratum in: J Cell Biol. 2011 Jan 10;192(1):201.

11.

Point mutations in c-Myc uncouple neoplastic transformation from multiple other phenotypes in rat fibroblasts.

Graves JA, Rothermund K, Wang T, Qian W, Van Houten B, Prochownik EV.

PLoS One. 2010 Oct 28;5(10):e13717. doi: 10.1371/journal.pone.0013717.

12.

Modulation of transcription factor function by O-GlcNAc modification.

Ozcan S, Andrali SS, Cantrell JE.

Biochim Biophys Acta. 2010 May-Jun;1799(5-6):353-64. doi: 10.1016/j.bbagrm.2010.02.005. Epub 2010 Mar 2. Review.

13.

Posttranslational regulation of Myc by promyelocytic leukemia zinc finger protein.

Shi J, Vogt PK.

Int J Cancer. 2009 Oct 1;125(7):1558-65. doi: 10.1002/ijc.24449.

14.

Inference of cell cycle-dependent proteolysis by laser scanning cytometry.

Chakraborty AA, Tansey WP.

Exp Cell Res. 2009 Jun 10;315(10):1772-8. doi: 10.1016/j.yexcr.2009.01.011. Epub 2009 Jan 27.

15.

Glycogen synthase kinase-3 inhibition induces glioma cell death through c-MYC, nuclear factor-kappaB, and glucose regulation.

Kotliarova S, Pastorino S, Kovell LC, Kotliarov Y, Song H, Zhang W, Bailey R, Maric D, Zenklusen JC, Lee J, Fine HA.

Cancer Res. 2008 Aug 15;68(16):6643-51. doi: 10.1158/0008-5472.CAN-08-0850.

16.

The Kaposi's sarcoma-associated herpesvirus LANA protein stabilizes and activates c-Myc.

Liu J, Martin HJ, Liao G, Hayward SD.

J Virol. 2007 Oct;81(19):10451-9. Epub 2007 Jul 18.

17.

A comprehensive map of the toll-like receptor signaling network.

Oda K, Kitano H.

Mol Syst Biol. 2006;2:2006.0015. Epub 2006 Apr 18. Review.

18.

A comprehensive pathway map of epidermal growth factor receptor signaling.

Oda K, Matsuoka Y, Funahashi A, Kitano H.

Mol Syst Biol. 2005;1:2005.0010. Epub 2005 May 25.

19.

Negative control of the Myc protein by the stress-responsive kinase Pak2.

Huang Z, Traugh JA, Bishop JM.

Mol Cell Biol. 2004 Feb;24(4):1582-94.

20.

Regulation of the resident chromosomal copy of c-myc by c-Myb is involved in myeloid leukemogenesis.

Schmidt M, Nazarov V, Stevens L, Watson R, Wolff L.

Mol Cell Biol. 2000 Mar;20(6):1970-81.

Supplemental Content

Support Center